Evidence map›Paper›PMID 35291664›Full record

ArticleInternational journal of hematology-oncology and stem cell research2021

Evaluation of the Preventive Effects of Carvedilol on Trastuzumab-Induced Cardiotoxicity in Early-Stage and Locally Advanced HER2-Positive Breast Cancer Patients.

Mohsen Esfandbod, Mina Naderi, Azadeh Sadatnaseri, Ayat Ahmadi, Mohammadtaghi Noroozi, Saeid Sadeghi Joni

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of hematology-oncology and stem cell research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mohsen EsfandbodDepartment of Clinical Hematology and Bone Marrow Transplantation, Vali-e-Asr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Mina NaderiDepartment of Internal Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Azadeh SadatnaseriDepartment of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ayat AhmadiKnowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadtaghi NorooziDepartment of Internal Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Saeid Sadeghi JoniDepartment of Radiology, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Tehran University of Medical Sciences · IRGuilan University of Medical Sciences · IRSina Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarvedilolEjection fractionHuman epidermal growth factor receptor-2 (HER-2)Pulmonary artery pressureTrastuzumab-induced cardiotoxicity

Identifiers

PMID35291664
PMCPMC8888356
OpenAlexW3206280370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.